UNITY Biotechnology Inc
Change company Symbol lookup
Select an option...
UBX UNITY Biotechnology Inc
HMNF HMN Financial Inc
BAM Brookfield Asset Management Inc
XOM Exxon Mobil Corp
NEWR New Relic Inc
T AT&T Inc
AICAF Air China Ltd
MMM 3M Co
JNJ Johnson & Johnson
TIP iShares TIPS Bond ETF
Go

Health Care : Biotechnology |
Company profile

Unity Biotechnology, Inc. is a clinical stage biotechnology company engaged in developing therapeutics to treat ageing related diseases. The Company develops therapeutics for age-associated diseases such as arthritis, vision loss, and cognitive decline. It develops a range of Senolytic medicines that eliminate senescent cells and stop the production of Senescence Associated Secretory Phenotype. Its pipelines of products that target cellular senescence are in its clinical development stage. Its lead products candidates include senolytic molecules, UBX0101 and UBX1967, designed for local treatment for the removal of accumulated senescent cells.UBX0101 is a drug candidate developed for musculoskeletal diseases targeting osteoarthritis. It is a inhibitor of the MDM2/p53 protein interaction that eliminates senescent cells. UBX1967 is targeted at ophthalmologic diseases. It is a senolytic small molecule inhibitor of specific members of the Bcl-2 family of apoptosis regulatory proteins.

Postmarket

Last Trade
Delayed
$3.42
-0.02 (-0.58%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$3.44
Day's Change
-0.03 (-0.86%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
3.49
Day's Low
3.35
Volume
(Light)
Volume:
464,841

10-day average volume:
1,179,541
464,841

Display:

Providers:

UpdateCancel
4 providers
August 18, 2020
Unity Biotechnology downgraded to neutral from buy at Mizuho

(END) Dow Jones Newswires August 18, 2020 06:25 ET (10:25 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.(MarketWatch)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.